Chemomab Therapeutics Ltd - ESG Rating & Company Profile powered by AI
If you are employed by Chemomab Therapeutics Ltd and you wish to use your Sustainability rating, please contact us. The analysis of Chemomab Therapeutics Ltd employs intelligence from across the web as well as from public disclosures by Chemomab Therapeutics Ltd. Other corporations in the rating peer group for Chemomab Therapeutics Ltd are shown.
Chemomab Therapeutics Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.8; made up of an environmental score of 5.3, social score of 3.2 and governance score of 6.0.
4.8
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
764 | Zoetis Inc | 4.9 | High |
764 | iCo Therapeutics Inc | 4.9 | High |
816 | Chemomab Therapeutics Ltd | 4.8 | High |
816 | Althea Group Holdings Ltd | 4.8 | High |
816 | Alkaloid AD Skopje | 4.8 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Chemomab Therapeutics Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Chemomab Therapeutics Ltd disclose current and historical energy intensity?
Does Chemomab Therapeutics Ltd report the average age of the workforce?
Does Chemomab Therapeutics Ltd reference operational or capital allocation in relation to climate change?
Does Chemomab Therapeutics Ltd disclose its ethnicity pay gap?
Does Chemomab Therapeutics Ltd disclose cybersecurity risks?
Does Chemomab Therapeutics Ltd offer flexible work?
Does Chemomab Therapeutics Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Chemomab Therapeutics Ltd disclose the number of employees in R&D functions?
Does Chemomab Therapeutics Ltd conduct supply chain audits?
Does Chemomab Therapeutics Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Chemomab Therapeutics Ltd conduct 360 degree staff reviews?
Does Chemomab Therapeutics Ltd disclose the individual responsible for D&I?
Does Chemomab Therapeutics Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Chemomab Therapeutics Ltd disclose current and / or historical scope 2 emissions?
Does Chemomab Therapeutics Ltd disclose water use targets?
Does Chemomab Therapeutics Ltd have careers partnerships with academic institutions?
Did Chemomab Therapeutics Ltd have a product recall in the last two years?
Does Chemomab Therapeutics Ltd disclose incidents of discrimination?
Does Chemomab Therapeutics Ltd allow for Work Councils/Collective Agreements to be formed?
Has Chemomab Therapeutics Ltd issued a profit warning in the past 24 months?
Does Chemomab Therapeutics Ltd disclose parental leave metrics?
Does Chemomab Therapeutics Ltd disclose climate scenario or pathway analysis?
Does Chemomab Therapeutics Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Chemomab Therapeutics Ltd disclose the pay ratio of women to men?
Does Chemomab Therapeutics Ltd support suppliers with sustainability related research and development?
Does Chemomab Therapeutics Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Chemomab Therapeutics Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Chemomab Therapeutics Ltd involved in embryonic stem cell research?
Does Chemomab Therapeutics Ltd disclose GHG and Air Emissions intensity?
Does Chemomab Therapeutics Ltd disclose its waste policy?
Does Chemomab Therapeutics Ltd report according to TCFD requirements?
Does Chemomab Therapeutics Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Chemomab Therapeutics Ltd disclose energy use targets?
Does Chemomab Therapeutics Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Chemomab Therapeutics Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Chemomab Therapeutics Ltd
These potential risks are based on the size, segment and geographies of the company.
Chemomab Therapeutics Ltd. engages in the research and development of biological drugs for the treatment of inflammatory and fibrotic diseases. The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 16, 2021. Chemomab Therapeutics Ltd. was incorporated in 2011 and is based in Tel Aviv, Israel.